Literature DB >> 1081549

Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.

A D Bankhurst, R C Williams.   

Abstract

Antigen-ginding lymphocytes capable of binding native DNA (DNA-ABC) were identified in the peripheral blood of normal controls and patients with systemic lupus erythematosus (SLE) by autoradiography with 125I-nDNA. 12 patients with active SLE had 404 +/- 273 (mean +/- SD) DNA-ABC/105 lymphocytes, while 7 inactive SLE patients and 13 normals had 120 +/- 48 and 48 +/- 36, respectively. All three groups were significantly different from one another (p less than 0.01). No significant correlation was detected between the quantity of anti-native DNA (nDNA) antibody and number of DNA-ABC; however, most patients with large amounts of anti-nDNA antibody had both active disease and large numbers of DNA-ABC. Numbers of DNA-ABC and lymphocytes with surface immunoglobulin (Ig) did not change significantly after an 18-h incubation at 37degreeC. After depletion of B-lymphocytes by passage over bead columns coated with a complex of IgG and anti-IgG, the great majority of DNA-ABC were removed in both normal subjects and SLE patients. Labeling lymphocytes sequentially with 125I-nDNA, followed by an indirect fluorescence technique for identification of surface Ig, indicated that the great mahority of radiolabeled cells had surface Ig by fluorescence microscopy in four normals (average 93%) and five patients with active SLF (average 82%). The predominance of nDNA-sensitive B-lymphocytes in the peripheral blood of both normals and SLE patients is consistent with the concept that the induction of the anti-nDNA antibody response is due to the stimulation of preexisting nDNA-specific B lymphocytes by mechanisms other than those necessarily involving participation of nDNA-specific T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081549      PMCID: PMC333115          DOI: 10.1172/JCI108218

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  The antigenic determinants of denatured DNA reactive with lupus erythematosus serum.

Authors:  D STOLLAR; L LEVINE; H I LEHRER; H VAN VUNAKIS
Journal:  Proc Natl Acad Sci U S A       Date:  1962-05-15       Impact factor: 11.205

2.  The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus.

Authors:  H HOLMAN; H R DEICHER
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

3.  Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein.

Authors:  H R HOLMAN; H G KUNKEL
Journal:  Science       Date:  1957-07-26       Impact factor: 47.728

4.  [Demonstration in the blood of patients with disseminated lupus erythematosus a substance determining a precipitation reaction with desoxyribonucleic acid].

Authors:  M SELIGMANN
Journal:  C R Hebd Seances Acad Sci       Date:  1957-07-08

5.  Complement fixation with cell nuclei and DNA in lupus erythematosus.

Authors:  W C ROBBINS; H R HOLMAN; H DEICHER; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Identification and quantitation of thymus-derived lymphocytes in human peripheral blood.

Authors:  A M Bobrove; S Strober; L A Herzenberg; J D DePamphilis
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

8.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

9.  Specific inactivation of antigen-reactive cells with 125I-labelled antigen.

Authors:  G L Ada; P Byrt
Journal:  Nature       Date:  1969-06-28       Impact factor: 49.962

10.  A receptor for antibody on B lymphocytes. I. Method of detection and functional significance.

Authors:  A Basten; J F Miller; J Sprent; J Pye
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  20 in total

1.  Autoimmunity to La (SS-B) in vitro is related to HLA-DR3 in healthy subjects.

Authors:  P J Venables; S Rigby; P A Mumford; J Markwick; R N Maini
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

Review 2.  Systemic lupus erythematosus--an autoimmune disease?

Authors:  E J Holborow
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

3.  Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

4.  Lymphocyte surface markers in acute rheumatic fever and post-streptococcal acute glomerulonephritis.

Authors:  R C Williams; J B Zabriskie; F Mahros; F Hassaballa; Z H Abdin
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

5.  Single and double stranded DNA binding lymphocytes in the peripheral blood of patients with systemic lupus erythematosus and normal controls.

Authors:  S Slavin; D Sulitzeanu
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

6.  Antibodies to polyadenylic acid in patients with myasthenia gravis.

Authors:  M Fischbach; J Lindstrom; N Talal
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

7.  Lymphocytes binding C-reactive protein during acute rheumatic fever.

Authors:  R C Williams; K A Kilpatrick; M Kassaby; Z H Abdin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

8.  Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus.

Authors:  N I Abdou; H Wall; H B Lindsley; J F Halsey; T Suzuki
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis.

Authors:  N Olsen; M Ziff; H E Jasin
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

10.  Anti-ssDNA and antinuclear antibodies in human malaria.

Authors:  D Adu; D G Williams; I A Quakyi; A Voller; Y Anim-Addo; A A Bruce-Tagoe; G D Johnson; E J Holborow
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.